Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05974046 · ClinicalTrials.gov registry record · Phase 1
Single Dose Study of [14C]-IDV184001AN ([14C]-IDV184001) in Healthy Adult Male Participants
A Phase 1 study, sponsored by Indivior.
- Completed
- Registry status
- Phase 1
- Development phase
- 7
- Enrollment target
NCT05974046 is a Phase 1 study that has completed, run by Indivior. The registered enrollment target is 7 participants.
The verdict
NCT05974046, a Phase 1 study, has completed, sponsored by Indivior.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 7 participants
- Enrollment target
Study Summary
The purpose of this open label study is to characterise the absorption, metabolism, excretion, and mass balance of \[14C\]-IDV184001AN (\[14C\]-IDV184001) in healthy adult male participants.
Interventions
- DRUG [14C]IDV184001AN
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2023-07-10 |
| Est. Completion | 2023-07-21 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05974046
The ClinicalTrials.gov registry entry for NCT05974046 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indivior, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which [14C]IDV184001AN is the first listed.
NCT05974046 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05974046 about?
NCT05974046 is a clinical study titled "Single Dose Study of [14C]-IDV184001AN ([14C]-IDV184001) in Healthy Adult Male Participants". The purpose of this open label study is to characterise the absorption, metabolism, excretion, and mass balance of \[14C\]-IDV184001AN (\[14C\]-IDV184001) in healthy adult male participants.
What is the current status of trial NCT05974046?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 7 participants. The study started on 2023-07-10. Estimated completion is 2023-07-21.
What interventions are being tested in trial NCT05974046?
The interventions under investigation include: [14C]IDV184001AN (DRUG).
Who is sponsoring clinical trial NCT05974046?
This trial is sponsored by Indivior, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.